Covaxin
-
Bharat Biotech ramps up Covaxin production, to now manufacture 1 billion doses per year
India | May 20, 2021 21:46 ISTBharat Biotech has said it plans to produce additional 200 million doses of COVID-19 vaccine at its subsidiary's Ankleshwar in Gujarat based facility, taking overall production volume of the vaccine to 1 billion (100 crore) dosages per annum.
-
Covid vaccine will be available for all by December: JP Nadda
India | May 20, 2021 15:55 ISTBJP president JP Nadda said that coronavirus vaccine will be available for all in the country by December.
-
More pharma firms should be allowed to make Covid vaccine: Gadkari
India | May 19, 2021 12:31 ISTThere are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield, respectively. Only three vaccines have so far been approved to be sold in India --- Covaxin, Coveshield and Sputnik V.
-
Covaxin trial on children to begin in 10-12 Days: Govt
News | May 19, 2021 8:00 ISTNiti Aayog member VK Paul said Covaxin has been approved by the Drugs Controller General of India (DCGI) for phase II and III clinical trials in the age group of 2 to 18 years. “I have been told that trials will begin in the next 10-12 days," Dr Paul said.
-
Delhi receives over 60,000 Covaxin doses for 45-plus, key workers: Atishi
India | May 18, 2021 19:47 ISTDelhi on Tuesday received over 60,000 Covaxin doses for key workers and those aged above 45, AAP MLA Atishi said.
-
Covaxin clinical trials for 2-18 age group to begin in next 10-12 days: Govt
India | May 18, 2021 18:11 ISTThe clinical trials of Bharat Biotech's Covaxin in the age group of 2-18 years will begin in next 10-12 days, the government said Tuesday. The development comes days after India's apex drugs regulator granted permission for conducting the phase II/III clinical trials.
-
WHO reminds Serum Institute of its COVAX commitments amidst devastating COVID-19 outbreak
Business | May 18, 2021 11:10 ISTWHO chief Tedros Adhanom Ghebreyesus has said that once the devastating COVID-19 outbreak in India recedes, the Serum Institute of India will need to “get back on track and catch up” on its delivery commitments to COVAX, the global initiative to supply coronavirus vaccines to nations around the world.
-
Only a day's stock of Covaxin for 45-plus in Delhi, Covishield to last for 5 days: Delhi govt
India | May 17, 2021 19:08 ISTAAP MLA Atishi Marlena on Monday said that the national capital was running out of vaccine stock. Raising an alarm, Atishi claimed that Delhi has less than a day's stock of Covaxin for 45-plus after Monday evening while Covisheild will last only for five days.
-
Bharat Biotech's Karnataka facility to manufacture 5 crore Covaxin doses by August-end
India | May 17, 2021 16:34 ISTBharat Biotech's Covaxin manufacturing facility is under construction in Kolar district of Karnataka.
-
Bleeding, clotting events following Covid vaccination 'minuscule' in India: Govt
India | May 18, 2021 0:00 ISTAlerts have been raised in some countries on post-vaccination "embolic and thrombotic events" on 11 March, 2021 particularly with AstraZeneca-Oxford vaccine (Covishield in India).
-
Telangana pauses second dose of Covaxin due to inadequate stock
India | May 17, 2021 6:51 ISTTelangana, which claims to have the capacity to give 10 lakh vaccines every day, is administering 30,000 to 40,000 vaccines daily due to the shortage. On May 14, the health authorities administered about 34,000 vaccines.
-
DRDO's anti-COVID drug 2-DG's first batch to be released today
India | May 17, 2021 0:02 ISTThe first batch of anti-COVID drug 2-DG, developed by the DRDO, will be released on Monday (May 17) by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan, officials said.
-
Booking for 2nd dose of vaccine on CoWIN portal? This is what you need to know
India | May 17, 2021 0:00 ISTRequisite changes have now been made on the CoWIN digital portal, making online or on-site appointments for Covishield vaccine not possible if the period after first dose for a beneficiary is less than 84 days, it was announced on Sunday.
-
Covaxin for those above 45 years to last only one day: Delhi govt
India | May 16, 2021 19:34 ISTDelhi has so far received 44.94 lakh vaccine doses for this age group, of which 41.68 lakh have been administered, she said.
-
Hester in talks with Bharat Biotech for production of Covaxin via technology transfer
India | May 16, 2021 18:31 ISTHester Biosciences on Sunday said it has tied up with the Gujarat government to explore production of COVID-19 vaccine through technology transfer from Bharat Biotech. The Ahmedabad-based firm said it has already initiated the discussions with Bharat Biotech in this regard.
-
COVAXIN effective against coronavirus strains found in India, UK
India | May 16, 2021 14:49 ISTAs per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared to the vaccine variant (D614G).
-
Gujarat govt in talks with Bharat Biotech to ramp up production of Covaxin: DBT
India | May 15, 2021 23:50 ISTTo ramp up production of Covaxin, the Gujarat government, along with Hester Biosciences and OmniBRx, has firmed up its discussions with Bharat Biotech to produce 20 million doses per month, the Department of Biotechnology (DBT) said on Saturday.
-
COVID-19: How safe are you after taking both doses of coronavirus vaccine?
News | May 15, 2021 17:14 ISTA rapid vaccination drive continues to overcome coronavirus. As of now, Covaxin and Covshield are being administered across the country for people above 18 years of age. However, the burning question is -- are we completely safe after inoculation of two doses? Here's what LNGP Director Dr Suresh Kumar and Dr Kaushalkant Mishra of Fortis Hospital shared with India TV during Corona Control Conference.
-
Centre to supply 192 lakh doses of Covid vaccine to states in 15 days free of cost
India | May 14, 2021 23:56 ISTThe cumulative number of COVID-19 vaccine doses administered in the country is nearly 18 crore. India is the fastest country globally to reach the 17 crore target in 114 days.
-
Covaxin dispatched to various states like Gujarat, Assam: Bharat Biotech
India | May 14, 2021 13:38 ISTThe Hyderabad-based vaccine major, which has come under fire from the Delhi government over supply-related issues, said it has also dispatched Covaxin lots to Kerala and Uttarakhand.
Top News
-
Trump cuts short talks with Zelenskyy, says 'he disrespected US, can come back when ready for peace'
-
Zelenskyy says 'Thank you, America' as his US visit ends abruptly after Oval Office spat with Trump
-
Watch: Zelenskyy leaves White House without signing minerals deal with Trump
-
Trump warns Zelenskyy in heated White House meeting: 'You're gambling with World War III'
Latest News
-
Zelenskyy says 'Thank you, America' as his US visit ends abruptly after Oval Office spat with Trump
-
Trump cuts short talks with Zelenskyy, says 'he disrespected US, can come back when ready for peace'
-
Watch: Zelenskyy leaves White House without signing minerals deal with Trump
-
Trump, Zelenskyy get into heated argument in Oval Office: 'You are in no position to dictate'
-
Ryan ten Doeschate indicates changes in India's playing XI, selection still a dilemma
Trending
-
Kolkata-based couple chose not to send their kids to school, call it 'waste of time' | Watch
-
Millions join debate over the colour of the viral dress, 'White and Gold or Blue and Black?'
-
Pakistan man surprises his bride-to-be with a Shah Rukh Khan-style visit before wedding | Watch
-
Aerial video of Varanasi goes viral, showcasing sacred city's divine essence | Watch
-
'BEWARE BCP is watching you' says Bengaluru police as bikers perform dangerous stunts on road